The phase 2a proof-of-concept trial will recruit up to 135 adult patients with mild to severe PPP to investigate the efficacy and safety of delgocitinib cream compared to cream vehicle. Delgocitinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback